Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes
- PMID: 3596636
- PMCID: PMC1453385
Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes
Abstract
A factor that inhibits the growth of mitogen-stimulated lymphocytes from normal donors has been detected in the sera of patients with chronic leprosy. The inhibitory activity was detected with similar frequency in patients with tuberculoid or lepromatous leprosy, although higher levels of activity were detected in the latter. The factor reduced the growth in volume of the lymphocytes in the first 24 hr after stimulation, the synthesis of RNA during the first 3 days of culture and the replication of DNA in 72-hr cultures. All the inhibitory activity co-purified with IgG on gel filtration, ammonium sulphate fractionation and ion exchange chromatography. The activity was stable to heating at 56 degrees but labile at 100 degrees and was absorbed from serum or from purified IgG preparations by staphylococcal protein A. On gel filtration of the sera on Sephadex G-200, none of the activity appeared in the void volume, indicating that it is not due to immune complexes. We conclude that the activity is due to an IgG antibody and suggest that it is an autoantibody since the sera inhibited the growth of all donor lymphocytes tested.
Similar articles
-
The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.Immunology. 1987 Jun;61(2):125-9. Immunology. 1987. PMID: 3496268 Free PMC article.
-
Suppress of the increase in free cytosolic calcium during the inhibition of T-cell activation by an autoantibody present in the serum of leprosy patients.Immunology. 1989 Nov;68(3):353-8. Immunology. 1989. PMID: 2592010 Free PMC article.
-
Serum lymphocytotoxic activity in leprosy.Clin Exp Immunol. 1989 Jun;76(3):391-7. Clin Exp Immunol. 1989. PMID: 2752595 Free PMC article.
-
Effects of lepromatous leprosy (LL) serum factor(s) on normal blood lymphocytes.Int J Lepr Other Mycobact Dis. 1990 Dec;58(4):666-73. Int J Lepr Other Mycobact Dis. 1990. PMID: 2280117
-
Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment.Clin Exp Immunol. 1975 Dec;22(3):385-92. Clin Exp Immunol. 1975. PMID: 131666 Free PMC article.
Cited by
-
Antigen-specific B-cell unresponsiveness induced by chronic Mycobacterium avium subsp. paratuberculosis infection of cattle.Infect Immun. 1999 Apr;67(4):1593-8. doi: 10.1128/IAI.67.4.1593-1598.1999. Infect Immun. 1999. PMID: 10084991 Free PMC article.
-
The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.Immunology. 1987 Jun;61(2):125-9. Immunology. 1987. PMID: 3496268 Free PMC article.
-
Cytogenetic studies in leprosy patients before and after chemotherapy.Hum Genet. 1991 Oct;87(6):665-70. doi: 10.1007/BF00201722. Hum Genet. 1991. PMID: 1937467
-
Tuberculous anergic sera or purified protein derivative treatment induces modification in lymphocyte transformation of cells from patients with tuberculosis.J Clin Microbiol. 1990 Feb;28(2):344-9. doi: 10.1128/jcm.28.2.344-349.1990. J Clin Microbiol. 1990. PMID: 2312677 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical